Scarica l'app Stockscreener
407.33
0.03%
-0.565
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VRTX Giù?
Forum
Previsione
Frazionamento azionario
Vertex Pharmaceuticals Inc Borsa (VRTX) Ultime notizie
Will Vertex Pharmaceuticals Incorporated bounce back from current supportJuly 2025 Final Week & Fast Gain Stock Tips - newser.com
Can Vertex Pharmaceuticals Incorporated stock resist sector downturnsWeekly Trade Review & Entry Point Confirmation Signals - newser.com
Custom watchlist performance reports with Vertex Pharmaceuticals IncorporatedJuly 2025 Decliners & Community Consensus Picks - newser.com
2 Unstoppable Growth Stocks to Buy During a Market Crash - The Motley Fool
Best Biotech Stocks To Follow NowOctober 10th - MarketBeat
Lobbying Update: $1,110,000 of VERTEX PHARMACEUTICALS INCORPORATED lobbying was just disclosed - Quiver Quantitative
11 Newly Overvalued Stocks this Week - Morningstar
Griffin Asset Management Inc. Cuts Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals (VRTX) Stock Analysis: Navigating a Promising 18% Upside in the Biotech Leader - DirectorsTalk Interviews
Is Vertex Pharmaceuticals Incorporated stock a safe investment in uncertain marketsProfit Target & Weekly Market Pulse Alerts - newser.com
Promising Biotech Stocks To Follow NowOctober 11th - MarketBeat
Why Vertex Pharmaceuticals Incorporated (VX1) stock signals breakout potentialJuly 2025 Technicals & AI Powered Buy/Sell Recommendations - newser.com
Apollon Wealth Management LLC Purchases 4,630 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Meritage Portfolio Management Decreases Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Stake Increased by Vanguard Personalized Indexing Management LLC - MarketBeat
US Bancorp DE Acquires 1,324 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Commerzbank Aktiengesellschaft FI Has $4.39 Million Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Acquired by Galvin Gaustad & Stein LLC - MarketBeat
Aberdeen Group plc Has $128.20 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Acquired by Callan Family Office LLC - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Blair William & Co. IL - MarketBeat
Vertex Pharma announces new share buybacks worth up to $4B - MSN
Vertex Pharmaceuticals (VRTX): Analyst Rating Update from Morgan Stanley | VRTX Stock News - GuruFocus
Pharma Compliance Trends Revealed at PCC West - BioXconomy
Recovering from injury, Boston Celtics star Jayson Tatum laces up for Vertex campaign - PRWeek
Evercore ISI Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX) - The Globe and Mail
Quantitative breakdown of Vertex Pharmaceuticals Incorporated recent moveWeekly Investment Recap & Technical Analysis for Trade Confirmation - newser.com
Vertex Pharmaceuticals Incorporated stock daily chart insightsJuly 2025 Setups & Risk Managed Investment Signals - newser.com
Trifecta Capital Advisors LLC Buys 802 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Optas LLC Lowers Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vontobel Holding Ltd. Decreases Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Weiss Ratings Reiterates "Hold (C+)" Rating for Vertex Pharmaceuticals (NASDAQ:VRTX) - MarketBeat
Here's Why Vertex Pharmaceuticals (VRTX) Fell More Than Broader Market - Yahoo Finance
Vertex Pharmaceuticals Experiences Evaluation Revision Amid Mixed Market Indicators - Markets Mojo
Is Vertex Stock Poised for Growth After Positive CRISPR Therapy Trial Results in 2025? - Yahoo Finance
RBC Capital Sticks to Its Hold Rating for Vertex Pharmaceuticals (VRTX) - The Globe and Mail
Odyssey Therapeutics Appoints Pharmaceutical Leader Nia Tatsis, Ph.D., to Its Board of Directors - Business Wire
Prime Capital Investment Advisors LLC Cuts Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals (NASDAQ:VRTX) Given New $530.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Vertex’s quest for a breakthrough in Type 1 diabetes - PharmaVoice
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know - Yahoo Finance
RBC Raises Price Target on Vertex Pharmaceuticals to $423 From $405, Keeps Sector Perform Rating - MarketScreener
Dohj LLC Purchases Shares of 857 Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
The Smartest Growth Stock to Buy With $500 Right Now - Yahoo Finance
The 5 Most Powerful Women in Biopharma - BioSpace
Vertex Pharmaceuticals (VRTX): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Vertex Pharmaceuticals Incorporated $VRTX Stake Lifted by KLP Kapitalforvaltning AS - MarketBeat
Shell Asset Management Co. Raises Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
SteelPeak Wealth LLC Makes New $10.06 Million Investment in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Simplicity Wealth LLC Purchases 1,736 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Is Vertex Pharmaceuticals a Smart Investment After Recent FDA Approval for Sickle Cell Therapy? - Sahm
Vertex to Announce Third Quarter 2025 Financial Results on November 3rd - Business Wire
Former Vertex COO named chief executive at Dravet-focused biotech - The Business Journals
What Makes Vertex Pharmaceuticals (VRTX) an Investment Bet? - Yahoo Finance
Vertex Pharmaceuticals: Strong Growth Potential with Promising Product Launches and Robust Pipeline - TipRanks
Cullinan Associates Inc. Sells 1,100 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Will Vertex Pharmaceuticals Incorporated price bounce be sustainableJuly 2025 Momentum & AI Enhanced Execution Alerts - newser.com
Published on: 2025-10-06 04:49:48 - newser.com
DAVENPORT & Co LLC Grows Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
2.72%
1.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):